Elaine Ullian, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 20,000 shares at $110.00 ($2.2M) on 2015-10-02, disclosed to the SEC on 2015-10-06.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HOLX | SELL | 2017-07-06 | $801K | — | Filing → |
| HOLX | SELL | 2017-06-06 | $786K | — | Filing → |
| HOLX | SELL | 2017-05-05 | $799K | — | Filing → |